Distribution of Rectal Cancer Stages at Raden Mattaher Regional Hospital, Jambi, 2023–2025
- Authors
-
-
-
Ivan Kurniawan Bassar
-
Rita Halim
-
Mohammad Rizal Syafiie
-
Huntari Harahap
-
- Keywords:
- Array, Array, Array, Array
- Abstract
-
Background: Rectal cancer is a major subtype of colorectal cancer with a global incidence that keeps increasing. Disease stage at diagnosis plays an important role in determining treatment strategies, prognosis, and patient outcomes. This study aimed to characterize the stage distribution of rectal cancer patients at Raden Mattaher General Hospital, Jambi within the period of 2023– 2025. Methods: This retrospective cross-sectional study used secondary data obtained from the medical records of rectal cancer patients at Raden Mattaher General Hospital, Jambi, between 2023 and 2025. Total sampling was employed. Of 252 medical records reviewed, 147 patients met the inclusion and exclusion criteria. Univariate analysis was performed to describe the distribution of rectal cancer stages. Results: A total of 147 patients were included in the analysis. Stage II was the most common stage, accounting for 48 patients (32.7%), followed by stage IV with 46 patients (31.3%), stage I with 24 patients (16.3%), stage III with 19 patients (12.9%), and stage 0 with 10 patients (6.8%). Discussion: The predominance of stage II indicates that most patients were diagnosed at an intermediate stage, while the substantial proportion of stage IV cases suggests delayed diagnosis in a considerable number of patients. These findings emphasize the importance of strengthening early detection, public awareness, and colorectal cancer screening programs. Conclusion: Stage II was the most frequently identified stage of rectal cancer among patients at Raden Mattaher General Hospital, Jambi, during 2023–2025, followed by stage IV. Most patients were diagnosed at intermediate to advanced stages, which indicates the need for improved early detection and screening strategies to achieve better clinical outcomes.
- Author Biographies
- References
-
1. Wu Z, Sun Y, Huang W, Jin Z, You F, Li X, et al. Direct and indirect effects of estrogens, androgens and intestinal microbiota on colorectal cancer. Front Cell Infect Microbiol. 2024 Nov 26;14.
2. Majid SR, Ariyanti F. Determinan kejadian kanker kolorektal. J Ilmu Kesehat Masy. 2020 Dec 14;9(04):208–15.
3. Zannah SJ, Murti IS, Sulistiawati S. Hubungan usia dengan stadium saat diagnosis penderita kanker kolorektal di RSUD Abdul Wahab Sjahranie Samarinda. J Sains dan Kesehat. 2021 Oct 31;3(5):701– 5.
4. Puspitaningtyas H, Hutajulu SH, Fachiroh J, Anggorowati N, Sanjaya GY, Lazuardi L, et al. Diverging likelihood of colon and rectal cancer in Yogyakarta, Indonesia: a cross sectional study. PLoS One. 2024 Mar 28;19(3):e0301191.
5. Aqsa MH. Prevalensi karsinoma kolorektal berdasarkan kelompok usia dan jenis kelamin pada pasien yang dirawat di rawat inap bedah RSUD Raden Mattaher Jambi tahun 2017–2021 [Skripsi]. Jambi: Universitas Jambi; 2022.
6. Sjamsuhidajat R, de Jong W. Buku ajar ilmu bedah: sistem organ dan tindak bedahnya (2). Edisi ke-4. Jakarta: EGC; 2019.
7. Adila A, Mustika SE. Hubungan usia dan jenis kelamin terhadap kejadian kanker kolorektal. J Kedokt STM (Sains dan Teknol Med). 2023 Jan 12;6(1):53–9.
8. Kim BJ, Hanna MH. Colorectal cancer in young adults. J Surg Oncol. 2023 Jun 24;127(8):1247–51.
9. Panda GS, Noronha V, Yadav S, Joshi A, Patil V, Menon N, et al. Small cell carcinoma of the oesophagus: experience of an Indian tertiary cancer centre. Ecancermedicalscience. 2022 May 19;16.
10. Lehtonen TM, Koskenvuo LE, Lepistö AH. Early-onset rectal cancer: experience of a single-center, high-volume unit. Scand J Surg. 2025 Mar 13;114(1):22–34.
11. Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-onset colorectal cancer: current insights. Cancers (Basel). 2023 Jun 15;15(12):3202.
12. Putranto AS, Julistian J. Risk factors of colorectal carcinoma incidence in young adults: a meta- analysis. New Ropanasuri J Surg. 2019 Apr 30;4(1):1–6.
13. Waldmann A, Borchers P, Katalinic A. Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany. BMC Cancer. 2023 Dec 1;23(1):1180. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11660-1.
14. Kooyker A, de Jonge L, Toes-Zoutendijk E, Spaander M, van Vuuren H, Kuipers E, et al. Colorectal cancer stage distribution at first and repeat fecal immunochemical test screening. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3424–3432.e2. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1542356523006535.
15. Kurniadi N, Utama MS, Purnama A. Profile of rectal cancer patients undergoing radiation therapy in Dr. Hasan Sadikin General Hospital from 2016 until 2021. Indones J Cancer. 2024 Mar;18(1):21–6. Available from: https://doi.org/10.33371/ijoc.v18i1.1020.
16. Lukman K, Muhammad A, Ghozali M, Nugraha P. Epidemiological and clinicopathological characteristics of colorectal cancer patients in a tertiary hospital in West Java. Clin Epidemiol Glob Health. 2024 Jul;28:101688. Available from: https://doi.org/10.1016/j.cegh.2024.101688.
17. Suryani ND, Wiranata JA, Puspitaningtyas H, Hutajulu SH, Prabandari YS, Handaya AY, et al. Determining factors of presentation and diagnosis delays in patients with colorectal cancer and the impact on stage: a cross sectional study in Yogyakarta, Indonesia. Ecancermedicalscience. 2024;18:1761. Available from: https://doi.org/10.3332/ecancer.2024.1761.
- Cover Image
-
- Downloads
- Published
- 2026-09-08
- Section
- Research Article
- License
-
Copyright (c) 2026 Dhiya Nazhifah Putri, Ivan Kurniawan Bassar, Rita Halim, Mohammad Rizal Syafiie, Huntari Harahap
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
